Getting the Full Story: The Importance of Ultra-Comprehensive Genomic Profiling in Advanced Cancer Therapy Selection
It’s difficult to imagine starting a cancer treatment path for a patient without first reviewing their molecular test results. This means getting the comprehensive story with DNA and RNA sequencing for all patients, most urgently those with advanced disease. In the past, we relied on DNA sequencing and small gene panels alone to find therapeutic targets. Today, rather than miss key biomarker information by relying on DNA sequencing alone, I consider it my duty as a pathologist to provide thorough, accurate, ultra-comprehensive testing that includes RNA sequencing up front to help oncologists make informed decisions.
